Infection Risk After Orthopaedic Surgery in Patients with Inflammatory Rheumatic Diseases, with Focus On Discontinuation of TNF-Alpha-Inhibitors

被引：0
|
作者：
Scherrer, Catrina B. [1 ]
Mannion, Anne A. F. [1 ]
Kyburz, Diego [2 ]
Vogt, Markus [3 ]
Kramers-de Quervain, Ines A. [1 ]
机构：
[1] Schulthess Clin, Zurich, Switzerland
[2] Ctr Exp Rheumatol, Zurich, Switzerland
[3] Cantonal Hosp Zug, Baar, Switzerland
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1669
引用
收藏
页码：S713 / S714
页数：2
相关论文
共 50 条
  • [1] Infection risk after orthopaedic surgery in patients with inflammatory rheumatic diseases treated with immunosuppressive drugs
    Scherrer, Catrina B.
    Mannion, Anne F.
    Kyburz, Diego
    Vogt, Markus
    Kramers-de Quervain, Ines A.
    [J]. SWISS MEDICAL WEEKLY, 2012, 142 : S2 - S2
  • [2] Chronic inflammatory Diseases Better Chances for persistent Remission with TNF-alpha-Inhibitors
    Bischoff, Angelika
    [J]. VISCERAL MEDICINE, 2017, 33 (01) : 90 - 90
  • [3] Effect og orthopaedic surgery in patients with inflammatory rheumatic diseases
    Dagfinrud, H.
    Hagen, K. B.
    Haukeland, E.
    Osnes, H.
    Kvien, T. K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 258 - 258
  • [4] Infection Risk After Orthopedic Surgery in Patients With Inflammatory Rheumatic Diseases Treated With Immunosuppressive Drugs
    Scherrer, Catrina B.
    Mannion, Anne F.
    Kyburz, Diego
    Vogt, Markus
    Kramers-de Quervain, Ine S. A.
    [J]. ARTHRITIS CARE & RESEARCH, 2013, 65 (12) : 2032 - 2040
  • [5] Four-years retention rate of golimumab administered after discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases
    Manuel Pombo-Suárez
    Daniel Seoane-Mato
    Federico Díaz-González
    Fernando Sánchez-Alonso
    Marta Sánchez-Jareño
    Luis Cea-Calvo
    Isabel Castrejón
    [J]. Advances in Rheumatology, 63
  • [6] Four-years retention rate of golimumab administered after discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases
    Pombo-Suarez, Manuel
    Seoane-Mato, Daniel
    Diaz-Gonzalez, Federico
    Sanchez-Alonso, Fernando
    Sanchez-Jareno, Marta
    Cea-Calvo, Luis
    Castrejon, Isabel
    [J]. ADVANCES IN RHEUMATOLOGY, 2023, 63 (01)
  • [7] GOLIMUMAB AFTER DISCONTINUATION OF NON-TNF INHIBITORS IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: FOUR-YEAR RETENTION RATE IN THE SPANISH BIOBADASER REGISTRY
    Pombo-Suarez, M.
    Seoane-Mato, D.
    Diaz-Gonzalez, F.
    Sanchez-Alonso, F.
    Cea-Calvo, L.
    Sanchez-Jareno, M.
    Jovani, V.
    Pretel, P.
    Ruiz, F. J. Manero
    Castrejon, I.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1504 - 1505
  • [8] The effectiveness for prevention of tuberculosis in patients with inflammatory rheumatic diseases treated with TNF inhibitors
    Rybar, I
    Rozborilova, E.
    Zanova, E.
    Micekova, D.
    Sojovic, I
    Rovensky, J.
    [J]. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2008, 109 (04): : 164 - 167
  • [9] Effects of TNF-α Inhibitors on Abdominal Adiposity in Patients with Inflammatory Rheumatic Diseases
    Toussirot, Eric
    Dumoulin, Gilles
    [J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (12) : 2491 - 2491
  • [10] Retention of golimumab treatment following discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases: An analysis of the Spanish BIOBADASER registry
    Pombo-Suarez, Manuel
    Sanchez-Piedra, Carlos
    Ruiz-Montesino, Dolores
    Diaz-Torne, Cesar
    Jovani, Vega
    Cea-Calvo, Luis
    Castrejon, Isabel
    [J]. MUSCULOSKELETAL CARE, 2022, 20 (02) : 403 - 407
12345